tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
PremiumThe FlyEdesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
2M ago
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
Premium
Company Announcements
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
2M ago
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
Premium
Company Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
2M ago
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
PremiumCompany AnnouncementsEdesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
5M ago
EDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
EDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Edesa Biotech files $150M mixed securities shelf
Premium
The Fly
Edesa Biotech files $150M mixed securities shelf
5M ago
Edesa Biotech assumed with a Buy at H.C. Wainwright
PremiumThe FlyEdesa Biotech assumed with a Buy at H.C. Wainwright
6M ago
Edesa Biotech Shareholders Approve Key Proposals at AGM
Premium
Company Announcements
Edesa Biotech Shareholders Approve Key Proposals at AGM
7M ago
Deckers downgraded, Morgan Stanley upgraded: Wall Street’s top analyst calls
Premium
The Fly
Deckers downgraded, Morgan Stanley upgraded: Wall Street’s top analyst calls
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100